Clinical Trials Browser

Phase 1/2 × INDUSTRY × UV1 vaccine × Clear all

NCT02275416 2024-12-16

Safety of UV1 Vaccination in Combination With Ipilimumab in Patients With Unresectable or Metastatic Malignant Melanoma

Phase 1/2 Completed

Melanoma